(Bloomberg) — The Bank of Japan sent shock waves through markets after it unexpectedly revised its yield-curve-control policy, signaling that the developed world’s last holdout to rock-bottom interest rates is inching toward policy normalization. The yen soared almost 3% to 133.11 per dollar, while yields on 10-year bonds surged 20.5 basis points to the highest […]
Read More(Bloomberg) — Walt Disney Co. fell on Monday, with the media company extending a lengthy selloff that took the stock to a more than two-year low. Its shares fell 4.8% to $85.78, ending at their lowest since March 2020 after a fourth day of losses. The slump came after a somewhat disappointing opening weekend for […]
Read More(Bloomberg) — Coinbase Global Inc., the largest public digital-asset exchange in the US, is trailing behind meme cryptocurrency Dogecoin in terms of market value. The exchange now has about $8 billion in market capitalization while the value of Dogecoin — originally created as a joke in 2013 — is topping $9 billion. The measurement does […]
Read MoreCal-Maine Foods, Inc., together with its subsidiaries, produces, grades, packages, markets, and distributes shell eggs. The company offers specialty shell eggs, such as nutritionally enhanced, cage free, organic, and brown eggs under the Egg-Land’s Best, Land O’ Lakes, Farmhouse Eggs, and 4-Grain brand names, as well as under private labels. CALM $60.6700 0.6400 % 1.0700 […]
Read MoreBioXcel Therapeutics, Inc. (BTAI) BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company’s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates. Astria Therapeutics, Inc. (ATXS) Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization […]
Read MoreCollegium Pharmaceutical, Inc. (COLL) Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone. General Mills, Inc. (GIS) General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores […]
Read MoreBuy Price: $5.15 or better Sell Price: TradersPro Sell Signal Genworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans. The stocks founds in the One Hot […]
Read MoreSince before 2020, I’ve been writing about the wisdom in being very selective about the investments you make. That includes taking a defensive approach by looking for industries and businesses whose operations aren’t as sensitive to the and ebb and flow of economic growth. Prepackaged food stocks like Hormel Foods Corp (HRL), CPB, and KHC […]
Read More(Bloomberg) — BlackRock Inc. strategists say traders that have started to bet on a sharp slowdown in inflation are setting themselves up for disappointment. While they acknowledge that prices pressures are ebbing faster than expected, they contest consensus bets that see the rate tumbling toward the Federal Reserve’s 2% target. That’s leading the world’s biggest […]
Read MoreMarket conditions are Bearish in a Bear Market as of 2022-12-16. This means traders and investors should consider trading with a Bearish bias by shorting stocks, buying inverse-ETF’s or buying put options. The rank of the Bear Market is -13.50 which indicates the current market conditions are Extreme, Risk of a reversal is high. The […]
Read More(Bloomberg) — US equities are set for their worst year since the global financial crisis, and, according to Morgan Stanley strategist Michael Wilson, corporate profits are about to meet the same fate. A looming earnings recession “by itself could be similar to what transpired in 2008/2009,” said Wilson. That could spark a new stock-market low […]
Read More